Vijay Kasturi

Vijay Kasturi currently serves as the Chief Medical Officer at CG Oncology, a position held since August 2023. Prior to this role, Vijay Kasturi was Vice President of Clinical Development and Medical Affairs at AVEO Oncology from April 2021 to August 2023, and held various leadership roles at FerGene, including Senior Vice President of Scientific Affairs and Vice President of Medical Affairs from March 2020 to March 2021. Vijay Kasturi's extensive experience in oncology includes serving as Head of US Medical Affairs for Oncology at EMD Serono, where responsibilities included leading the Global Medical Affairs for the Avelumab and Genitourinary Cancer Portfolio. Earlier career roles include serving as a physician at UMass Memorial Medical Center, Commonwealth Hematology Oncology, and Dartmouth Hitchcock Medical Center, specializing in genitourinary and lung cancers. Education credentials include an MD from Rush Medical College and a BSc in Biology from the University of Illinois Chicago, along with advanced training at the National Cancer Institute, NIH.